sodium picosulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4779 10040-45-6

Description:

MoleculeDescription

Synonyms:

  • sodium picosulfate
  • picosulfate sodium
  • picosulfol
  • rapilax
  • picolax
contains two active ingredients, sodium picosulfate and magnesium citrate, which are both laxatives; structure
  • Molecular weight: 481.40
  • Formula: C18H13NNa2O8S2
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 145.75
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
5 mg O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
July 16, 2012 FDA FERRING PHARMS AS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Food allergy 457.96 22.45 165 13691 25313 90589278
Immunodeficiency 379.86 22.45 167 13689 43067 90571524
Overdose 337.31 22.45 240 13616 157469 90457122
Intentional product misuse 313.94 22.45 186 13670 89418 90525173
Temperature regulation disorder 267.78 22.45 96 13760 14483 90600108
Prescribed overdose 249.63 22.45 166 13690 97459 90517132
Hyperhidrosis 249.59 22.45 189 13667 136116 90478475
Foetal death 218.00 22.45 91 13765 20632 90593959
Exposure during pregnancy 138.28 22.45 176 13680 238234 90376357
Cognitive disorder 115.40 22.45 91 13765 69316 90545275
Fluid retention 114.22 22.45 100 13756 87991 90526600
Creatinine renal clearance increased 109.90 22.45 34 13822 3247 90611344
Hypertension 107.52 22.45 224 13632 457308 90157283
Hyponatraemia 102.80 22.45 114 13742 133424 90481167
Renal function test abnormal 101.33 22.45 39 13817 7152 90607439
Reduced facial expression 96.35 22.45 29 13827 2524 90612067
Listless 93.56 22.45 30 13826 3219 90611372
Creatinine renal clearance decreased 92.67 22.45 49 13807 18850 90595741
Product use issue 92.45 22.45 174 13682 329745 90284846
Hepatic enzyme increased 92.24 22.45 183 13673 360553 90254038
Sedation complication 88.99 22.45 46 13810 16898 90597693
Urinary retention 84.03 22.45 59 13797 37685 90576906
Rash erythematous 82.55 22.45 73 13783 65031 90549560
Constipation 82.42 22.45 151 13705 280244 90334347
Coeliac disease 81.78 22.45 62 13794 44548 90570043
Multiple drug therapy 77.80 22.45 32 13824 6977 90607614
Apathy 72.84 22.45 35 13821 11005 90603586
Decreased immune responsiveness 67.81 22.45 31 13825 8717 90605874
Psoriasis 67.14 22.45 97 13759 147657 90466934
Blood calcium decreased 66.76 22.45 47 13809 30135 90584456
Cholestatic liver injury 65.93 22.45 24 13832 3773 90610818
Ileus 62.17 22.45 36 13820 16510 90598081
Orthostatic hypotension 61.36 22.45 51 13805 41776 90572815
Thrombocytopenia 58.26 22.45 110 13746 208615 90405976
Infusion related reaction 58.01 22.45 167 13689 416613 90197978
Depressed level of consciousness 55.72 22.45 62 13794 72722 90541869
Hypersensitivity 55.56 22.45 174 13682 454503 90160088
Sedation 55.13 22.45 51 13805 48120 90566471
Head discomfort 54.72 22.45 33 13823 16300 90598291
Off label use 53.27 22.45 318 13538 1101934 89512657
Drug interaction 53.06 22.45 125 13731 276328 90338263
Upper respiratory tract infection 52.20 22.45 80 13776 128238 90486353
Foreign body 51.77 22.45 18 13838 2476 90612115
Altered state of consciousness 49.50 22.45 40 13816 31492 90583099
Immobile 47.48 22.45 22 13834 6376 90608215
Prescription drug used without a prescription 47.10 22.45 18 13838 3237 90611354
Hypokalaemia 46.79 22.45 77 13779 131039 90483552
Pyrexia 45.91 22.45 211 13645 660274 89954317
Peripheral swelling 45.60 22.45 5 13851 413101 90201490
Arthralgia 43.96 22.45 33 13823 778489 89836102
Alopecia 43.63 22.45 11 13845 495060 90119531
Drug abuse 43.26 22.45 58 13798 82289 90532302
Abdominal discomfort 41.30 22.45 11 13845 477317 90137274
Sinusitis 40.96 22.45 3 13853 343085 90271506
Joint swelling 40.43 22.45 168 13688 503132 90111459
Affect lability 37.34 22.45 27 13829 18036 90596555
General physical health deterioration 37.14 22.45 129 13727 354986 90259605
Product prescribing error 36.60 22.45 33 13823 30112 90584479
Swelling 35.60 22.45 10 13846 419048 90195543
Inappropriate antidiuretic hormone secretion 35.49 22.45 27 13829 19478 90595113
Drug ineffective 34.90 22.45 103 13753 1384195 89230396
Fracture 34.64 22.45 28 13828 22048 90592543
Dehydration 34.14 22.45 85 13771 194362 90420229
Weight increased 33.64 22.45 11 13845 417916 90196675
Nasopharyngitis 32.27 22.45 11 13845 407093 90207498
Pelvic fracture 32.04 22.45 23 13833 15196 90599395
Balance disorder 31.94 22.45 55 13801 97025 90517566
Delirium 30.33 22.45 56 13800 104303 90510288
Bursitis 29.08 22.45 63 13793 131591 90483000
Restlessness 28.31 22.45 31 13825 35689 90578902
Encephalopathy 27.96 22.45 35 13821 46409 90568182
Oxygen saturation decreased 27.93 22.45 55 13801 107428 90507163
Abdominal rigidity 26.29 22.45 11 13845 2501 90612090
Blister 25.92 22.45 4 13852 254994 90359597
Paraesthesia 25.28 22.45 4 13852 250322 90364269
Electrolyte imbalance 24.98 22.45 24 13832 23721 90590870
Bedridden 24.75 22.45 18 13838 12130 90602461
Psoriatic arthropathy 24.58 22.45 3 13853 228332 90386259
Pruritus 24.55 22.45 28 13828 541497 90073094
Fall 24.37 22.45 141 13715 481669 90132922
Depression 24.02 22.45 8 13848 300593 90313998
Asthenia 23.76 22.45 28 13828 533723 90080868
Retching 23.31 22.45 21 13835 19138 90595453
Chest pain 23.06 22.45 10 13846 319635 90294956
Product dose omission issue 22.90 22.45 8 13848 291679 90322912
Paraneoplastic rash 22.55 22.45 5 13851 128 90614463

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Appendicolith 437.31 19.43 163 13241 13293 42594638
Appendicitis 389.54 19.43 169 13235 20444 42587487
Blood phosphorus increased 308.20 19.43 124 13280 12401 42595530
Ventricular fibrillation 302.59 19.43 160 13244 29963 42577968
General physical health deterioration 280.39 19.43 288 13116 150958 42456973
Cardiogenic shock 280.07 19.43 161 13243 35479 42572452
Abdominal distension 260.17 19.43 200 13204 71535 42536396
Ascites 243.49 19.43 175 13229 56503 42551428
Stress 243.13 19.43 159 13245 44053 42563878
Myasthenia gravis 206.49 19.43 101 13303 16036 42591895
Hyponatraemia 201.91 19.43 201 13203 101261 42506670
Blood uric acid increased 186.11 19.43 93 13311 15454 42592477
Multiple organ dysfunction syndrome 170.80 19.43 180 13224 96855 42511076
Dry mouth 168.54 19.43 122 13282 39757 42568174
Hyperphosphataemia 168.17 19.43 82 13322 12922 42595009
Blood cholesterol increased 156.30 19.43 100 13304 26641 42581290
Incorrect route of product administration 144.80 19.43 92 13312 24213 42583718
Abdominal pain 144.52 19.43 233 13171 190238 42417693
Constipation 136.19 19.43 208 13196 162083 42445848
Iron deficiency 131.87 19.43 66 13338 10995 42596936
Hypophosphataemia 131.57 19.43 82 13322 20863 42587068
Bacterial infection 130.94 19.43 91 13313 27788 42580143
Sleep disorder therapy 128.36 19.43 56 13348 6838 42601093
Neuralgia 123.46 19.43 85 13319 25562 42582369
Drug therapy 116.11 19.43 51 13353 6329 42601602
Diabetes mellitus 104.74 19.43 111 13293 59976 42547955
Sepsis 96.60 19.43 201 13203 199133 42408798
Somnolence 92.67 19.43 162 13242 140943 42466988
Vomiting 91.36 19.43 247 13157 289476 42318455
Swelling 74.43 19.43 89 13315 54796 42553135
Thrombosis 66.21 19.43 94 13310 68417 42539514
Chronic obstructive pulmonary disease 66.08 19.43 90 13314 63024 42544907
Intentional product misuse 65.92 19.43 89 13315 61811 42546120
Antacid therapy 64.74 19.43 31 13373 4686 42603245
Aortic stenosis 64.58 19.43 38 13366 8707 42599224
Nausea 63.19 19.43 269 13135 396530 42211401
Sleep disorder 61.96 19.43 76 13328 48019 42559912
Bacteroides infection 61.47 19.43 25 13379 2562 42605369
Anticoagulant therapy 56.81 19.43 28 13376 4507 42603424
Drug intolerance 56.19 19.43 95 13309 80329 42527602
Drug ineffective 54.92 19.43 71 13333 630126 41977805
Activated partial thromboplastin time prolonged 54.57 19.43 43 13361 15860 42592071
End stage renal disease 50.94 19.43 42 13362 16516 42591415
Ulcer 49.11 19.43 41 13363 16400 42591531
Anaemia 47.61 19.43 194 13210 280084 42327847
Drug hypersensitivity 42.02 19.43 95 13309 99294 42508637
Dehiscence 41.27 19.43 13 13391 633 42607298
Total lung capacity decreased 38.74 19.43 20 13384 3550 42604381
Fatigue 35.89 19.43 51 13353 435590 42172341
Pulmonary embolism 34.56 19.43 99 13305 119513 42488418
Hyperlipidaemia 34.38 19.43 38 13366 21478 42586453
Troponin increased 32.78 19.43 35 13369 19027 42588904
Gout 32.40 19.43 42 13362 28013 42579918
Blood calcium increased 31.48 19.43 24 13380 8430 42599501
Lung opacity 27.25 19.43 19 13385 5818 42602113
Rash 26.33 19.43 29 13375 276925 42331006
Toxicity to various agents 25.27 19.43 21 13383 229115 42378816
Condition aggravated 25.25 19.43 154 13250 260600 42347331
Arthralgia 24.95 19.43 17 13387 205221 42402710
Cholestatic liver injury 24.49 19.43 15 13389 3694 42604237
Abdominal neoplasm 24.25 19.43 8 13396 452 42607479
Ileus 24.23 19.43 30 13374 19109 42588822
Bronchopulmonary aspergillosis allergic 23.91 19.43 16 13388 4582 42603349
Analgesic therapy 23.15 19.43 18 13386 6506 42601425
Blood test abnormal 22.73 19.43 24 13380 12882 42595049
Neuropathy peripheral 19.74 19.43 4 13400 101849 42506082
Faecaloma 19.48 19.43 16 13388 6254 42601677

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Appendicolith 498.20 19.75 169 25713 14086 110549331
Appendicitis 427.25 19.75 182 25700 28282 110535135
Blood phosphorus increased 336.07 19.75 131 25751 16209 110547208
Ventricular fibrillation 321.81 19.75 168 25714 41145 110522272
Hyponatraemia 294.85 19.75 306 25576 217347 110346070
Ascites 282.06 19.75 207 25675 92601 110470816
Cardiogenic shock 270.46 19.75 168 25714 57170 110506247
General physical health deterioration 257.68 19.75 400 25482 424895 110138522
Constipation 229.97 19.75 346 25536 357440 110205977
Myasthenia gravis 228.35 19.75 108 25774 21403 110542014
Blood uric acid increased 207.01 19.75 101 25781 21428 110541989
Abdominal distension 199.81 19.75 225 25657 174878 110388539
Hyperphosphataemia 198.01 19.75 90 25792 16291 110547126
Multiple organ dysfunction syndrome 176.57 19.75 197 25685 151513 110411904
Stress 175.60 19.75 166 25716 105182 110458235
Intentional product misuse 174.63 19.75 184 25698 132720 110430697
Sleep disorder therapy 164.64 19.75 63 25819 7408 110556009
Hypophosphataemia 153.32 19.75 96 25786 33086 110530331
Drug therapy 151.82 19.75 59 25823 7232 110556185
Iron deficiency 137.73 19.75 73 25809 18403 110545014
Temperature regulation disorder 134.89 19.75 64 25818 12762 110550655
Bacterial infection 133.73 19.75 100 25782 45936 110517481
Sepsis 130.08 19.75 256 25626 327090 110236327
Neuralgia 116.24 19.75 94 25788 48384 110515033
Diabetes mellitus 113.76 19.75 128 25754 99253 110464164
Food allergy 113.56 19.75 66 25816 19882 110543535
Foetal death 112.87 19.75 61 25821 15984 110547433
Abdominal pain 111.60 19.75 317 25565 512672 110050745
Incorrect route of product administration 104.89 19.75 100 25782 63961 110499456
Somnolence 104.36 19.75 221 25661 297228 110266189
Creatinine renal clearance increased 92.36 19.75 34 25848 3591 110559826
Antacid therapy 88.68 19.75 37 25845 5447 110557970
Anticoagulant therapy 79.46 19.75 34 25848 5327 110558090
Ileus 78.81 19.75 62 25820 30667 110532750
Altered state of consciousness 77.79 19.75 81 25801 57545 110505872
Renal function test abnormal 77.18 19.75 39 25843 8907 110554510
Aortic stenosis 76.44 19.75 44 25838 13015 110550402
Vomiting 76.15 19.75 416 25466 910259 109653158
Immunodeficiency 75.99 19.75 67 25815 38771 110524646
Cholestatic liver injury 75.10 19.75 36 25846 7340 110556077
Anaemia 74.82 19.75 289 25593 546797 110016620
Urinary retention 68.45 19.75 83 25799 69600 110493817
Head discomfort 68.31 19.75 47 25835 18953 110544464
Listless 68.13 19.75 29 25853 4486 110558931
Activated partial thromboplastin time prolonged 68.11 19.75 50 25832 22318 110541099
Reduced facial expression 67.10 19.75 27 25855 3624 110559793
Creatinine renal clearance decreased 66.96 19.75 49 25833 21766 110541651
Bacteroides infection 65.69 19.75 25 25857 2894 110560523
End stage renal disease 65.38 19.75 48 25834 21425 110541992
Thrombosis 65.22 19.75 102 25780 108560 110454857
Sedation complication 64.13 19.75 46 25836 19809 110543608
Peripheral swelling 62.23 19.75 10 25872 404024 110159393
Drug ineffective 61.70 19.75 169 25713 1520371 109043046
Chronic obstructive pulmonary disease 60.76 19.75 99 25783 109059 110454358
Multiple drug therapy 60.67 19.75 32 25850 7982 110555435
Cognitive disorder 59.41 19.75 87 25795 87424 110475993
Sinusitis 57.10 19.75 3 25879 296685 110266732
Coeliac disease 57.02 19.75 60 25822 43127 110520290
Nausea 56.24 19.75 486 25396 1235204 109328213
Overdose 56.16 19.75 150 25732 233644 110329773
Arthralgia 54.91 19.75 61 25821 779571 109783846
Decreased immune responsiveness 52.60 19.75 31 25851 9575 110553842
Dry mouth 49.76 19.75 130 25752 199818 110363599
Apathy 48.76 19.75 36 25846 16203 110547214
Weight increased 48.12 19.75 19 25863 419625 110143792
Blood calcium decreased 47.68 19.75 50 25832 35795 110527622
Total lung capacity decreased 47.13 19.75 26 25856 7088 110556329
Abdominal discomfort 46.55 19.75 17 25865 393841 110169576
Therapeutic product effect decreased 45.39 19.75 3 25879 244313 110319104
Alopecia 44.38 19.75 15 25867 364738 110198679
Gout 43.36 19.75 48 25834 36518 110526899
Pyrexia 43.23 19.75 358 25524 897907 109665510
Paraesthesia 42.21 19.75 7 25875 276514 110286903
Upper respiratory tract infection 41.89 19.75 94 25788 131234 110432183
Amaurosis fugax 41.61 19.75 17 25865 2373 110561044
Hyperlipidaemia 40.69 19.75 46 25836 35802 110527615
Troponin increased 40.45 19.75 42 25840 29724 110533693
Prescribed overdose 40.27 19.75 73 25809 87508 110475909
Hypokalaemia 39.77 19.75 113 25769 182335 110381082
Dehiscence 38.75 19.75 12 25870 746 110562671
Foreign body 37.91 19.75 17 25865 2978 110560439
Immobile 37.38 19.75 23 25859 7679 110555738
Rash erythematous 37.36 19.75 68 25814 81764 110481653
Ulcer 36.98 19.75 48 25834 43068 110520349
Depressed level of consciousness 35.40 19.75 80 25802 112198 110451219
Orthostatic hypotension 35.39 19.75 59 25823 66190 110497227
Memory impairment 34.93 19.75 3 25879 196941 110366476
Psoriatic arthropathy 34.89 19.75 3 25879 196758 110366659
Blood cholesterol increased 34.17 19.75 108 25774 184677 110378740
Fluid retention 34.07 19.75 71 25811 94236 110469181
Pain in extremity 33.28 19.75 39 25843 487079 110076338
Lung opacity 33.13 19.75 25 25857 11627 110551790
Blood calcium increased 33.06 19.75 30 25852 18010 110545407
Urinary tract disorder 32.37 19.75 19 25863 5825 110557592
Pulmonary embolism 31.45 19.75 116 25766 214358 110349059
Sleep disorder 31.31 19.75 110 25772 198534 110364883
Blister 30.10 19.75 8 25874 227368 110336049
Faecaloma 29.72 19.75 26 25856 14882 110548535
Depression 29.43 19.75 19 25863 317316 110246101
Drug interaction 29.37 19.75 209 25673 499974 110063443
Analgesic therapy 28.52 19.75 19 25863 7265 110556152
Prescription drug used without a prescription 28.18 19.75 17 25865 5479 110557938
Inappropriate antidiuretic hormone secretion 27.96 19.75 37 25845 33814 110529603
Malaise 27.60 19.75 74 25808 671745 109891672
Therapeutic product effect incomplete 27.56 19.75 9 25873 223796 110339621
Musculoskeletal pain 27.12 19.75 5 25877 183018 110380399
Urticaria 27.05 19.75 21 25861 318836 110244581
Chest pain 26.93 19.75 29 25853 376346 110187071
Delirium 26.89 19.75 81 25801 134944 110428473
Fatigue 26.73 19.75 171 25711 1215787 109347630
Nasopharyngitis 26.47 19.75 32 25850 394329 110169088
Therapy non-responder 26.32 19.75 3 25879 157304 110406113
Product dose omission issue 26.29 19.75 22 25860 321760 110241657
Folliculitis 26.13 19.75 4 25878 167649 110395768
Wheezing 25.46 19.75 14 25868 255216 110308201
Osteoarthritis 24.99 19.75 6 25876 182617 110380800
Affect lability 24.79 19.75 26 25856 18611 110544806
Sedation 24.63 19.75 52 25830 69631 110493786
Pneumonia aspiration 24.63 19.75 57 25825 81176 110482241
Injection site pain 24.04 19.75 6 25876 177916 110385501
Arthritis 23.95 19.75 5 25877 167581 110395836
Ill-defined disorder 23.86 19.75 4 25878 156849 110406568
Hypoaesthesia 23.86 19.75 23 25859 314200 110249217
Bronchopulmonary aspergillosis allergic 23.78 19.75 18 25864 8408 110555009
Congenital hiatus hernia 23.72 19.75 16 25866 6243 110557174
Benign prostatic hyperplasia 23.47 19.75 25 25857 18209 110545208
pH body fluid increased 23.08 19.75 5 25877 73 110563344
Pelvic fracture 22.97 19.75 22 25860 14132 110549285
Thrombocytopenia 22.97 19.75 150 25732 348735 110214682
Dyspepsia 22.96 19.75 8 25874 190957 110372460
Intentional product use issue 22.76 19.75 15 25867 247891 110315526
Product prescribing error 22.60 19.75 42 25840 51289 110512128
Pruritus 22.43 19.75 66 25816 581494 109981923
Drug intolerance 22.20 19.75 167 25715 406345 110157072
Fall 22.09 19.75 227 25655 603255 109960162
Fracture 21.89 19.75 28 25854 24760 110538657
Blood test abnormal 21.74 19.75 30 25852 28524 110534893
Hyperhidrosis 21.59 19.75 94 25788 187204 110376213
Liver function test increased 21.42 19.75 57 25825 88491 110474926
Systemic infection 21.35 19.75 18 25864 9801 110553616
Heart rate increased 21.16 19.75 4 25878 143830 110419587
Asthenia 20.68 19.75 87 25795 688912 109874505
Abdominal rigidity 20.48 19.75 12 25870 3668 110559749
Gait disturbance 20.39 19.75 21 25861 278187 110285230
Hepatic function abnormal 20.12 19.75 56 25826 89239 110474178
Maternal exposure during pregnancy 20.12 19.75 18 25864 254865 110308552

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A06AB08 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR CONSTIPATION
DRUGS FOR CONSTIPATION
Contact laxatives
ATC A06AB58 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR CONSTIPATION
DRUGS FOR CONSTIPATION
Contact laxatives
MeSH PA D002400 Cathartics
MeSH PA D005765 Gastrointestinal Agents
CHEBI has role CHEBI:50503 laxative

Related Drugs by ATC class:

A06AB Contact laxatives 6 drugs
bisacodylbisoxatincastor oildantronoxyphenisatinephenolphthalein

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Colonoscopy indication 73761001




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
12GM/BOT;3.5GM/BOT;10MG/BOT CLENPIQ FERRING PHARMS INC N209589 Nov. 28, 2017 RX SOLUTION ORAL 11191753 June 23, 2034 FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY
12GM/BOT;3.5GM/BOT;10MG/BOT CLENPIQ FERRING PHARMS INC N209589 Nov. 28, 2017 RX SOLUTION ORAL 12576072 June 23, 2034 FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY
12GM/BOT;3.5GM/BOT;10MG/BOT CLENPIQ FERRING PHARMS INC N209589 Nov. 28, 2017 RX SOLUTION ORAL 9827231 June 26, 2034 FOR CLEANSING THE LARGE INTESTINE AS A PREPARATION FOR COLONOSCOPY

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
LR57574HN8 UNII
4032318 VUID
N0000186955 NUI
4032318 VANDF
C0071042 UMLSCUI
CHEBI:32147 CHEBI
CHEMBL1697768 ChEMBL_ID
68654 PUBCHEM_CID
C005701 MESH_SUPPLEMENTAL_RECORD_UI
DB14232 DRUGBANK_ID
33688 RXNORM
18056 MMSL
d04939 MMSL
003762 NDDF
317558003 SNOMEDCT_US
395881001 SNOMEDCT_US
C0058139 UMLSCUI
69046 PUBCHEM_CID
1307301-38-7 SECONDARY_CAS_RN

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
SODIUM PICOSULFATE, MAGNESIUM OXIDE AND ANHYDROUS CITRIC ACID HUMAN PRESCRIPTION DRUG LABEL 3 31722-874 POWDER, METERED 10 mg ORAL ANDA 25 sections
CLENPIQ HUMAN PRESCRIPTION DRUG LABEL 3 55566-6800 LIQUID 10 mg ORAL NDA 31 sections